Subsea7 SA (SUBC)
Verdict history · SUBC
Every call Verdix has made on SUBC.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior WAIT hinged on two price levels: a pullback into 290–316 or a breakout above 358.20. With the stock at 338, neither trigger fired, yet the fundamental case has firmed — three voices now see sufficient value at the current price, while the two holdouts still want the same pullback. The verdict shifts to BUY not because the price improved (it dipped 2%), but because the panel’s center of gravity moved toward accepting that the FCF yield and backlog visibility justify owning the stock even without a perfect entry.
See methodology for how verdicts are produced. Full track record →
The panel’s case for SUBC — and where they disagree.
The case for outweighs the case against at today's price.
OSL · Energy · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyLOW confidence
Why
Five investing frameworks assess Subsea 7 at 338 NOK: three call it a buy on a 14% free‑cash‑flow yield, net‑cash balance sheet, and DCF upside to ~400, while two hold out for a pullback to 290–316, creating a low‑conviction bullish consensus centered on whether a cyclical near its all‑time high still offers enough margin of safety.Level to watch
Key resistance 353.4+4.6% from 338
Next catalyst
Trigger to confirm the breakout: A weekly close above 358.20 with expanding volume and a positive MACD histogram flip would validate the Stage 2 uptrend and likely pull both neutral voices off the sidelines.The panel's take
Verdict: BUY · Conviction: LOW · Last price: 338.0 · Changed from WAIT
Panel: 3 Bullish · 2 Neutral · 0 Bearish → BUY
What changed since 2026-08-15:
- Price: 345.2 → 338.0 (-2.09%)
- Panel: 1 of 6 → 3 of 5 now Bullish — composition also changed: added none; removed The Macro Opportunist
- Trigger: SELL trigger: a weekly close below 290.20 NOK (the 38.2% Fibonacci retracement of the 180–358 rally, also the zone where the weekly EMA50 sits at 277.20) would break the Stage 2 uptrend and signal the cyclical thesis is failing. The prior article's breakout trigger at 358.20 still stands as a bullish confirmation level.
- Verdict: WAIT → BUY
The prior WAIT hinged on two price levels: a pullback into 290–316 or a breakout above 358.20. With the stock at 338, neither trigger fired, yet the fundamental case has firmed — three voices now see sufficient value at the current price, while the two holdouts still want the same pullback. The verdict shifts to BUY not because the price improved (it dipped 2%), but because the panel’s center of gravity moved toward accepting that the FCF yield and backlog visibility justify owning the stock even without a perfect entry.
The prior WAIT trigger was not fired: price at 338 sits 3% above the 290–316 pullback zone and 6% below the 358.20 breakout close, so neither condition has been met. The verdict shifts to BUY (LOW confidence) because three voices see sufficient value at the current price — the fundamental scout scores it 7.5/10, The Intrinsic-Value Modeler's DCF yields ~400 NOK (18% upside), The Asymmetric Bargainer sees a 14% FCF yield with Dhandho asymmetry, and The Forensic Skeptic calls it a 25–33% margin-of-safety opportunity — while the two holdouts (The Moat Compounder and The GARP Operator) both like the business but object only on timing, wanting a pullback to the same 290–316 zone the prior article named.
Key levels
Key levels · SUBC
NOK · as of 2026-08-22Analyst consensus target 353.33 NOK · range 239.64–457.38
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key support at 316.20–317.25 is the confluence of the weekly 23.6% Fibonacci and the EMA20, which is the first line buyers reclaimed on this rally; a break of that zone opens the door to 290.20, the 38.2% retracement and the level every voice cited as the threshold where Stage 2 fails. Key resistance is the all-time high at 358.20, tested and rejected on the weekly candle that formed the bearish MACD cross. The analyst consensus target of 353.33 NOK sits just below that ATH, reflecting the tension between a 4.5% implied upside and the market's hesitation at the top of the range.
What legendary investors think
We ran Subsea7 SA past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: The DCF points to ~400 NOK per share (18% upside) even under conservative mid‑cycle assumptions, driven by 12% near‑term revenue growth, margin expansion toward 15%, and a low reinvestment burden. Conviction: Conviction is tempered because the model rests on revenue and margin assumptions that extend 3–5 years into an uncertain energy cycle; a single miss on the growth trajectory would compress the terminal value materially.
The Asymmetric BargainerContrarian/Deep Value🟢 BullishMed
Signal: At 338 NOK the stock delivers a 14% trailing free‑cash‑flow yield backed by a net‑cash balance sheet, meaning the business could fund itself through a downturn while the market prices it like a peak‑cycle casualty. Conviction: Conviction stays high because three independent pillars point the same direction: a fortress balance sheet, cash conversion running 3.1x net income, and a backlog cycle that probably has two to three years of runway.
The Forensic SkepticContrarian/Forensic🟢 BullishMed
Signal: The market is discounting a severe downturn that the books do not support — 6.1x trailing free cash flow, net cash on hand, and a depreciated vessel fleet whose replacement cost far exceeds its carrying value create a 25–33% margin‑of‑safety opportunity. Conviction: Confidence is held in check by one unresolved dependency: working‑capital movements that could explain the wide gap between operating cash flow and net income, plus a backlog figure that was not supplied.
The Moat CompounderValue/Quality/Moat⚫ NeutralLow
Signal: Subsea 7 has a genuine narrow moat in deep‑water engineering — a specialized vessel fleet, an installed base, and a safety record that competitors cannot replicate overnight — but it is a cyclical business, not a forever compounder. Conviction: Conviction is restrained by the absence of a margin of safety at 338 NOK; the stock trades near its all‑time high with a weekly MACD bearish cross, and a pullback to the 290–316 zone would be required before the risk‑return profile fits the framework.
The GARP OperatorGrowth (GARP)⚫ NeutralMed
Signal: The PEG ratio of 0.70 and a forward P/E of 12.6x look cheap, but this is a cyclical that has already doubled from 180 to 358, and for cyclicals the time to buy is when the P/E is high and sentiment is lousy, not when earnings are surging. Conviction: Conviction is held back because the weekly MACD bearish cross at the all‑time high signals a timing mismatch; the fundamentals are fine, but the chart says the easy money is already made and patience is the smarter posture.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All five voices agree Subsea 7 is a fundamentally sound business: net cash, low leverage, high cash conversion, and a genuine competitive position in deep‑water engineering.
- All five agree the offshore cycle is still in an expansion phase and the balance‑sheet strength means the company survives even a sharp oil downturn.
- Nobody is outright bearish on the stock: even the two neutral voices are simply waiting for a better price, not arguing the business is overvalued or deteriorating.
The real debate
- The Asymmetric Bargainer and The Forensic Skeptic see the 14% FCF yield and 6.1x FCF multiple as evidence the market is mispricing the durability of cash generation, while The Moat Compounder and The GARP Operator argue that a cyclical stock near its all‑time high with a bearish weekly MACD cross does not offer the requisite margin of safety or timing entry.
- The Intrinsic-Value Modeler calculates a DCF value of ~400 NOK and is comfortable owning at 338, while The Moat Compounder insists on a pullback to 270–290 before the margin of safety becomes compelling — the same business, two different frameworks, and the disagreement is purely about price discipline versus value recognition.
The question it comes down to: Does a 14% free‑cash‑flow yield with a net‑cash balance sheet justify buying a cyclical stock near its all‑time high, or is waiting for a pullback to the 290–316 zone the pricier mistake if the cycle extends another two years?
The bottom line
- Trigger to confirm the breakout: A weekly close above 358.20 with expanding volume and a positive MACD histogram flip would validate the Stage 2 uptrend and likely pull both neutral voices off the sidelines.
- Risk to monitor: A weekly close below 290.20 (the 38.2% Fibonacci retracement) would break the Stage 2 structure and signal the cyclical thesis is failing.
- Next catalyst: Q2 2026 earnings, expected in early September, will test the upward revision trend; a beat with raised guidance could trigger the next wave of analyst upgrades beyond the recent Berenberg (415) and DNB (400) targets.
- Further out: Sustained Brent crude below $65/bbl would dry up project awards and unwind the entire investment case across all five archetypes.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · Founder holds a direct position in SUBC · SUBC verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated